Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 3471-3476, August 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blakeslee, J. R.
Right arrow Articles by Hinuma, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blakeslee, J. R., Jr.
Right arrow Articles by Hinuma, Y.

Human T-Cell Leukemia Virus I Induction by 5-lodo-2'-deoxyuridine and N-Methyl-N'-nitro-N-nitrosoguanidine: Inhibition by Retinoids, L-Ascorbic Acid, and DL-{alpha}-Tocopherol1

James R. Blakeslee, Jr.2, Naoki Yamamoto and Yorio Hinuma

Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606, Japan [J. R. B., N. Y., Y. H.], and The Department of Veterinary Pathobiology, The Ohio State University, Columbus, Ohio 43210-1093 [J. R. B.]

Human T-cell leukemia virus type I was induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and 5-iodo-2'-deoxyuridine (IdUrd) in the MT-1 cell line. Virus expression was monitored by immunofluorescence microscopy with GIN-14, mouse monoclonal antibodies directed toward Mr 19,000 and Mr 28,000 protein-specific virus polypeptides. MNNG (0.1 µg/ml) and IdUrd (50 µg/ml) both induced virus synthesis in MT-1 cells. MNNG-induced virus expression peaked between 24 and 48 h of incubation, whereas IdUrd induced maximum virus expression between 48 and 72 h of incubation. Superinduction resulted when MNNG was added to cells induced 48 h previously with IdUrd, but not with concomitant treatment. 13-cis-Retinoic acid, retinol, retinol aldehyde, and retinol acetate (10-6 to 10-9 M) were concomitantly added with IdUrd to MT-1 cells for 24, 48, and 72 h incubation. All inhibited virus induction to various degrees. The retinoids were ranked as to inhibitory activity: retinol > retinoic acid > retinol aldehyde > retinol acetate. The most sensitive period for inhibiting IdUrd induction by retinoic acid was 24 h postinduction or with concomitant treatment. Vitamin C and vitamin E inhibited IdUrd induction most effectively with 48 h incubation. Retinol and vitamin C also inhibited virus induction by MNNG. None of the retinoids, vitamin C, or vitamin E significantly inhibited virus expression in noninduced cells or were toxic to the cells at the concentrations used in these experiments.

1 Supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, The Ministry of Health and Welfare, Japan.

2 The author gratefully acknowledges the support of the Japan Society for the Promotion of Science and The Ohio State University. To whom requests for reprints should be addressed.

Received 12/ 6/84. Revised 5/ 6/85. Accepted 5/ 8/85.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.